REREP2Y

Across TCGA pan-cancer cohorts, REREP2Y RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated REREP2Y data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher REREP2Y RNA is associated with worse overall survival. In most high-consensus cancer types, elevated REREP2Y expression acts as an unfavorable survival marker.

STAD and ESCA are the cancer types where REREP2Y RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	All	0.184	0.730	.001	63	view →
ESCA	DFS	Tertile	All	0.126	0.536	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

REREP2Y–STAD (OS)

Open the STAD breakdown →